Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01115803
What this trial is testing

LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors

Who this might be right for
Metastases, NeoplasmCarcinoma, Non-small Cell LungRenal Cell Carcinoma+1 more
Eli Lilly and Company 29
Testing effectiveness (Phase 2)Looking for participantsNCT05363280
What this trial is testing

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

Who this might be right for
Small Cell Lung CancerRenal Cell Carcinoma (RCC)Non-Small Cell Lung
Advenchen Pharmaceuticals, LLC. 80
Large-scale testing (Phase 3)Looking for participantsNCT06364631
What this trial is testing

CARE1 Pragmatic Clinical Trial

Who this might be right for
Metastatic Kidney CancerMetastatic Kidney Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris 1,250
Large-scale testing (Phase 3)Ended earlyNCT03729245
What this trial is testing

Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Nektar Therapeutics 623
Not applicableStudy completedNCT04005183
What this trial is testing

Renal Cell Carcinoma Microenvironment Discovery Project

Who this might be right for
Renal Cell Carcinoma
University Health Network, Toronto 146
Testing effectiveness (Phase 2)WithdrawnNCT00574483
What this trial is testing

Treatment of Advanced Renal Cell Carcinoma With Quinacrine

Who this might be right for
Renal Cell Carcinoma
Cleveland BioLabs
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07816770
What this trial is testing

MANTIS-RCC: Toripalimab-Axitinib Induction in TLS-Positive Advanced Non-Clear Cell and Renal Medullary Carcinomas

Who this might be right for
Metastatic Non-Clear Cell Renal Cell CarcinomaMetastatic Renal Medullary Carcinomas
Fudan University 30
Early research (Phase 1)Temporarily pausedNCT07181720
What this trial is testing

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Lung CancerAnaplastic Thyroid Carcinomas+3 more
Chongqing Precision Biotech Co., Ltd 90
Testing effectiveness (Phase 2)Looking for participantsNCT06642220
What this trial is testing

Ablative Radioembolization of Renal Cell Carcinoma Trial

Who this might be right for
Renal Cell Carcinoma (RCC)Radioembolization
Derek W. Cool 16
Early research (Phase 1)Active Not RecruitingNCT02298959
What this trial is testing

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Colorectal CarcinomaMetastatic Malignant Solid Neoplasm+12 more
National Cancer Institute (NCI) 59
Not applicableUnknownNCT02001493
What this trial is testing

Metabolomic Profiling in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Cambridge University Hospitals NHS Foundation Trust 60
Not applicableStudy completedNCT01720706
What this trial is testing

Thermal Ablation in Larger Liver and Kidney Tumours

Who this might be right for
Liver and Kidney Tumours
University Health Network, Toronto 12
Testing effectiveness (Phase 2)Study completedNCT00101114
What this trial is testing

Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage III Renal Cell Cancer+1 more
National Cancer Institute (NCI) 55
Not applicableStudy completedNCT02732652
What this trial is testing

Glycosaminoglycan Scores as Monitoring Biomarkers in Confined Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Chalmers University of Technology 72
Testing effectiveness (Phase 2)Looking for participantsNCT07594106
What this trial is testing

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)Clear Cell Renal Cell Carcinoma (ccRCC)
Regeneron Pharmaceuticals 265
Testing effectiveness (Phase 2)Study completedNCT02019693
What this trial is testing

The MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer

Who this might be right for
Kidney Cancer
National Cancer Institute (NCI) 20
Not applicableStudy completedNCT01887574
What this trial is testing

Renal Mass Registry

Who this might be right for
Renal Cell Carcinoma
Mayo Clinic 141
Testing effectiveness (Phase 2)Ended earlyNCT05119335
What this trial is testing

NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
ccRCCClear Cell Renal Cell CarcinomaKidney Cancer+14 more
NiKang Therapeutics, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT00265135
What this trial is testing

CNTO 328 in Subjects With Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Centocor, Inc. 68
Testing effectiveness (Phase 2)Study completedNCT00619268
What this trial is testing

Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Centre Leon Berard 160
Next Page